Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Spondylodiscitis and an aortic aneurysm due to Campylobacter coli.

Literature DB >> 20132561

Spondylodiscitis and an aortic aneurysm due to Campylobacter coli.

Xavier Lemaire¹, Caroline Dehecq, Christian Cattoen, Laurence Destrieux Garnier, Béatrice Sarraz Bournet, Yazdan Yazdanpanah, Eric Senneville.

Abstract

Campylobacter coli is a rare cause of bacteremia. We report here the first case of C.coli spondylodiscitis complicated by an aortic aneurysm. Outcome was favourable with surgery and antibiotic therapy.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2010 PMID： 20132561 PMCID： PMC2828987 DOI： 10.1186/1476-0711-9-8

Source DB: PubMed Journal: Ann Clin Microbiol Antimicrob ISSN： 1476-0711 Impact factor: 3.944

28 in total

1. [Long-term antibiotic suppressive therapy for an infected thoracic aorta graft].

Authors: Jan-Erik Berdal; Martin Steinbakk
Journal: Tidsskr Nor Laegeforen Date: 2003-08-28

2. Relapsing cellulitis associated with Campylobacter coli bacteremia in an agammaglobulinemic patient.

Authors: Koichi Tokuda; Junichiro Nishi; Hiroaki Miyanohara; Jav Sarantuya; Mayumi Iwashita; Akira Kamenosono; Kazuko Hizukuri; Naoko Wakimoto; Masao Yoshinaga
Journal: Pediatr Infect Dis J Date: 2004-06 Impact factor: 2.129

3. [Hematologic manifestations in Campylobacter coli septicemia. Apropos of a case].

Authors: V Brunel; T Allegre; S Caillères; A P Blanc
Journal: Rev Med Interne Date: 1993-01 Impact factor: 0.728

4. Treatment of Pseudomonas aeruginosa-infected orthopedic prostheses with ceftazidime-ciprofloxacin antibiotic combination.

Authors: P Brouqui; M C Rousseau; A Stein; M Drancourt; D Raoult
Journal: Antimicrob Agents Chemother Date: 1995-11 Impact factor: 5.191

5. Bacteraemia as a result of Campylobacter species: a population-based study of epidemiology and clinical risk factors.

Authors: H Nielsen; K K Hansen; K O Gradel; B Kristensen; T Ejlertsen; C Østergaard; H C Schønheyder
Journal: Clin Microbiol Infect Date: 2010-01 Impact factor: 8.067

6. A survey of Campylobacter bacteremia in three Danish counties, 1989 to 1994.

Authors: H C Schønheyder; P Søgaard; W Frederiksen
Journal: Scand J Infect Dis Date: 1995

7. Bacteraemia caused by Campylobacter spp.

Authors: C Ladrón de Guevara; J Gonzalez; P Peña
Journal: J Clin Pathol Date: 1994-02 Impact factor: 3.411

8. Successful therapy of experimental chronic foreign-body infection due to methicillin-resistant Staphylococcus aureus by antimicrobial combinations.

Authors: C Chuard; M Herrmann; P Vaudaux; F A Waldvogel; D P Lew
Journal: Antimicrob Agents Chemother Date: 1991-12 Impact factor: 5.191

3. A nationwide study of Campylobacter jejuni and Campylobacter coli bacteremia in Finland over a 10-year period, 1998-2007, with special reference to clinical characteristics and antimicrobial susceptibility.

Authors: Benjamin Feodoroff; Anneli Lauhio; Patrik Ellström; Hilpi Rautelin
Journal: Clin Infect Dis Date: 2011-10 Impact factor: 9.079

3 in total